Log in

Efficacy of optical frequency-domain imaging in detecting peripheral artery disease: a single-center open-label, single-arm study protocol

  • Original Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

A Correction to this article was published on 29 June 2020

This article has been updated

Abstract

Intravascular optical coherence tomography is a high-resolution intracoronary imaging modality, providing a microscopic image of intravascular features. However, it has lower penetration depth than intravascular ultrasound. Recently, a second-generation optical frequency-domain imaging (OFDI) technique has been developed to provide greater penetration depth and faster pullback speed. However, there is little evidence supporting the efficacy of OFDI in patients with peripheral artery disease (PAD) undergoing endovascular treatment (EVT). We aimed to evaluate the ability of OFDI to visualize vessel walls from the superficial femoral artery (SFA) to the below-knee (BK) arteries, as well as the coronary arteries. This clinical trial is a single-center, single-arm, open-label study to be conducted in Japan. A total of 20 patients will be enrolled in this study. The primary endpoint is to obtain a clear image of the intravascular features of the SFA and BK arteries, specifically the visualization of ≥ 270° of the vessel lumen in ≥ 16 out of 21 cross sections. Obtaining clear images in ≥ 85% of cases will be regarded as confirmation of the ability of OFDI to visualize vessel walls from the SFA to the BK arteries. This is the first clinical trial to be conducted accordance with good clinical practice to expand the indications of OFDI for PAD patients undergoing EVT in Japan. The result of this study will help provide another imaging option during EVT in daily practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

  • 29 June 2020

    In the original publication of the article, the author group was published without full names and one of the co-authors’ name was published incorrectly. The full names of author group and correct co-authors’ name are given in this Correction.

References

  1. Rigatelli G, Cardaioli P, Giordan M. Endovascular treatment of femoro-popliteal obstructive disease. Minerva Cardioangiol. 2007;55:125–32.

    CAS  PubMed  Google Scholar 

  2. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thörne J, et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 1999;18:251–5.

    CAS  PubMed  Google Scholar 

  3. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420–5.

    Article  CAS  Google Scholar 

  4. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg. 2003;37:487–94.

    Article  Google Scholar 

  5. Kawasaki D, Tsu**o T, Fujii K, Masutani M, Ohyanagi M, Masuyama T. Novel use of ultrasound guidance for recanalization of iliac, femoral, and popliteal arteries. Catheter Cardiovasc Interv. 2008;71:727–33.

    Article  Google Scholar 

  6. Fujihara M, Kozuki A, Tsubakimoto Y, Takahara M, Shintani Y, Fukunaga M, et al. Lumen gain after endovascular therapy in calcified superficial femoral artery occlusive disease assessed by intravascular ultrasound (CODE Study). J Endovasc Ther. 2019;26:322–30.

    Article  Google Scholar 

  7. Okamura T, Gonzalo N, Gutierrez-Chico JL, et al. Reproducibility of coronary Fourier domain optical coherence tomography: quantitative analysis of in vivo stented coronary arteries using three different software packages. EuroIntervention. 2010;6:371–9.

    Article  Google Scholar 

  8. Miki K, Fujii K, Fukunaga M, Nishimura M, Horimatsu T, Saita T, et al. Strut coverage after paclitaxel-eluting stent implantation in the superficial femoral artery. JACC Cardiovasc Imaging. 2016;9:753–5.

    Article  Google Scholar 

  9. Ali ZA, Maehara A, Genereux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016;388:2618–28.

    Article  Google Scholar 

  10. Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Morino Y, et al. Optical frequency domain imaging vs intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J. 2017;38:3139–47.

    Article  Google Scholar 

  11. Otake H, Kubo T, Takahashi H, Shinke T, Okamura T, Hibi K, et al. Optical frequency domain imaging versus intravascular ultrasound in percutaneous coronary intervention (OPINION Trial): results from the OPINION Imaging Study. JACC Cardiovasc Imaging. 2018;11:111–23.

    Article  Google Scholar 

  12. Kozuki A, Shinke T, Otake H, Kijima Y, Masano T, Nagoshi R, et al. Optical coherence tomography study of chronic-phase vessel healing after implantation of bare metal and paclitaxel-eluting self-expanding nitinol stents in the superficial femoral artery. J Cardiol. 2016;67:424–9.

    Article  Google Scholar 

  13. Miki K, Fujii K, Shibuya M, Fukunaga M, Imanaka T, Tamaru H, et al. Comparing the vascular response in implantation of self-expanding, bare metal nitinol stents or paclitaxel-eluting nitinol stents in superficial femoral artery lesions: a serial optical frequency domain imaging study. EuroIntervention. 2016;12:1551–8.

    Article  Google Scholar 

  14. Miki K, Fujii K, Shibuya M, Fukunaga M, Imanaka T, Kawai K, et al. Impact of stent diameter on vascular response after self-expanding paclitaxel-eluting stent implantation in the superficial femoral artery. J Cardiol. 2017;70:346–52.

    Article  Google Scholar 

  15. Eberhardt KM, Treitl M, Boesenecker K, Maxien D, Reiser M, Rieger J. Prospective evaluation of optical coherence tomography in lower limb arteries compared with intravascular ultrasound. J Vasc Interv Radiol. 2013;24:1499–508.

    Article  Google Scholar 

  16. Marmagkiolis K, Lendel V, Cawich I, Leesar M, Feldman MD, Cilingiroglu M. Optical coherence tomography to guide below-the-knee endovascular interventions. Int J Cardiol. 2014;176:1336–8.

    Article  Google Scholar 

  17. Jang IK, Tearney G, Bouma B. Visualization of tissue prolapse between coronary stent struts by optical coherence tomography: comparison with intravascular ultrasound. Circulation. 2001;104:2754.

    Article  CAS  Google Scholar 

  18. Konishi A, Ho M, Shirai Y, Shirato H. First approval of improved medical device conditional on use-result survey in Japan—regulatory review of polymer-free drug-coated biofreedom coronary stent. Circul J. 2018;82:1487–90.

    Article  Google Scholar 

  19. Pharmaceuticals and Medical Devices Agency. Optical coherence tomography review report. 2015. [in Japanese]. http://www.pmda.go.jp/medical_devices/2007/M200700004/250011000_21900BZX00779000_A100_1.pdf. Accessed 22 Sep 2019.

  20. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24.

    Article  CAS  Google Scholar 

  21. Konishi A, Isobe S, Sato D. New regulatory framework for medical devices in Japan: current regulatory considerations regarding clinical studies. J Vasc Interv Radiol. 2018;29:657–60.

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to all of the staff involved in this clinical study.

Funding

This study project is funded by Terumo Corporation and supported by the Kobe Clinical and Translational Research Center.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Kawamori.

Ethics declarations

Conflicts of interest

Dr. Otake and Dr. Shinke serve as members of the advisory board of Abbott Vascular, Inc. The remaining authors have no conflicts of interest to declare.

Research involving human participants and/or animals

This protocol has been approved by the institutional review board of Kobe University Hospital (Protocol identification number: OFDI-01).

Informed consent

All patients must provide written informed consent. The principle investigator or sub-investigator will provide potential subjects with opportunities to ask questions and ample time to decide whether or not to provide consent, and should confirm sufficient understanding of the potential subjects about the contents of this study, before obtaining voluntary consent to participate.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 12 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawamori, H., Konishi, A., Otake, H. et al. Efficacy of optical frequency-domain imaging in detecting peripheral artery disease: a single-center open-label, single-arm study protocol. Cardiovasc Interv and Ther 35, 385–391 (2020). https://doi.org/10.1007/s12928-019-00636-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-019-00636-3

Keywords

Navigation